GlassScriptPhysician profile
Andrea Heaton
NPI 1891962486
$864.42
in general payments reported to CMS, 2019-2025
14 companies · $197 in 2025
The $197 reported for 2025 was more than what 75% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $154 · 2023: $153 · 2024: $245 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $154.50 | 2021-2024 | Bexsero, Pediarix, Rotarix |
| Corium, LLC | $136.62 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $130.82 | 2022-2024 | |
| Pfizer INC. | $78.82 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $59.53 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $50.35 | 2021-2023 | Vaxelis, M-M-R II, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $48.23 | 2021-2022 | |
| Neurelis, INC. | $48.05 | 2022-2025 | Valtoco |
| Tris Pharma INC | $36.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $33.23 | 2024 | Flumist Quadrivalent |
| Ucb, INC. | $29.20 | 2024 | Briviact |
| Sanofi Pasteur INC. | $26.06 | 2025 | |
| Supernus Pharmaceuticals, INC. | $18.71 | 2024 | Qelbree |
| Abbvie INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Heaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.